ConductScience.org, home

Paper41553019

Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.

Vissapragada R and 6 others. J Gastroenterol Hepatol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus. Papers, record 41553019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41553019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.
PubMed
Journal
J Gastroenterol Hepatol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vissapragada RRavi
2Bulamu NBNorma B
3Yazbeck RRogerhttps://orcid.org/0000-0002-1038-4998
4Aoki TTomonori
5Bright TTim
6Watson DIDavid I
7Karnon JJonathan

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Barrett EsophagusMajor topic
Cost-Benefit AnalysisMajor topic
Cost-Effectiveness AnalysisMajor topic
Esophageal NeoplasmsMajor topic
EsophagoscopyMajor topic
Population SurveillanceMajor topic
Humans
Markov Chains
Adenocarcinoma
Male
Female
Disease Progression
Time Factors

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Hospital Research FoundationPubMed
APAGE/JGH Foundation Clinician-Scientist Training FellowshipPubMed
Cancer Council South Australia Beat Cancer Early Career Research FellowshipPubMed

Source PubMed

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121997553The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.Gut2012https://conductscience.org/library/papers/21997553PubMed
231439127ASGE guideline on screening and surveillance of Barrett's esophagus.Gastrointest Endosc2019https://conductscience.org/library/papers/31439127PubMed
328389530Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia.Gut2018https://conductscience.org/library/papers/28389530PubMed
425612140Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.J Gastroenterol Hepatol2015https://conductscience.org/library/papers/25612140PubMed
526113177Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.Gut2016https://conductscience.org/library/papers/26113177PubMed
631749626A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus.Clinicoecon Outcomes Res2019https://conductscience.org/library/papers/31749626PubMed
733480173Cost-effectiveness in surgery: concepts of cost-utility analysis explained.ANZ J Surg2021https://conductscience.org/library/papers/33480173PubMed
826772891Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort.Gastrointest Endosc2016https://conductscience.org/library/papers/26772891PubMed
929689573Systematic review and meta-analysis of the effectiveness of radiofrequency ablation in low grade dysplastic Barrett's esophagus.Endoscopy2018https://conductscience.org/library/papers/29689573PubMed
1041553019Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.J Gastroenterol Hepatol2026https://conductscience.org/library/papers/41553019PubMed
1125935635An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling.Gastroenterology2015https://conductscience.org/library/papers/25935635PubMed
1222644445Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia.J Gastrointest Surg2012https://conductscience.org/library/papers/22644445PubMed
1328374819Disease Progression in Barrett's Low-Grade Dysplasia With Radiofrequency Ablation Compared With Surveillance: Systematic Review and Meta-Analysis.Am J Gastroenterol2017https://conductscience.org/library/papers/28374819PubMed
1427882416Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer.World J Surg2017https://conductscience.org/library/papers/27882416PubMed
1537081811Guidance on the use of complex systems models for economic evaluations of public health interventions.Health Econ2023https://conductscience.org/library/papers/37081811PubMed
1630213587Incidence of Progression of Persistent Nondysplastic Barrett's Esophagus to Malignancy.Clin Gastroenterol Hepatol2019https://conductscience.org/library/papers/30213587PubMed
1727227114Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability.Endosc Int Open2016https://conductscience.org/library/papers/27227114PubMed
1823542068Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.Gastroenterology2013https://conductscience.org/library/papers/23542068PubMed
1924589668Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.Am J Gastroenterol2014https://conductscience.org/library/papers/24589668PubMed
2015180723Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia.Am J Gastroenterol2004https://conductscience.org/library/papers/15180723PubMed

See all 48 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
41553019Evaluating Cost-Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus.J Gastroenterol Hepatol2026https://conductscience.org/library/papers/41553019

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41553019

GET https://conductscience.org/api/papers/v1/41553019/references?page=2